Thyroid Eye Disease (TED) Archives

Biggest Novel Drug Approvals in 2020

"Bad" LDL Cholesterol, Acute Migraine, Antibodies, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), EvaluatePharma, FDA, Future Blockbusters, New Drug Approvals, Peanut Allergies, Relapsing Multiple Sclerosis (RMS), Spinal Muscular Atrophy (SMA), Therapeutics, Thyroid Eye Disease (TED), Triple Negative Breast Cancer (TNBC)

BioSpace reviewed the top 10 novel drug approvals of 2020, loosely based on projected earnings in the upcoming years.

FDA Action Alert: Horizon, Bristol Myers Squibb, Merck, NewLink, Seattle Genetics and Astellas

Antibody-Drug Conjugates (ADCs), Ebola Virus, FDA, FDA/Regulatory, Hepatocellular Carcinoma, Prescription Drug User-Fee Act (PDUFA), Priority Review, Thyroid Eye Disease (TED), Vaccines

The U.S. Food and Drug Administration reviewed several drugs under Priority Review ahead of their PDUFA target action dates scheduled during the week of March 8th, 2020.

Horizon Therapeutics Wins FDA Approval for First Thyroid Eye Disease Treatment

Approvals, Autoimmune Disorders, FDA, FDA/Regulatory, Graves' Disease, Infusions, Monoclonal Antibodies, New Drug Application (NDA), Orphan Drug Designation, Priority Review, Proptosis (Eye Bulging), Rare Diseases, Thyroid Eye Disease (TED), Thyroid Hormones

Ireland’s Horizon Therapeutics became the first to win regulatory approval in the United States for the treatment of Thyroid Eye Disease (TED), a progressive autoimmune disorder that can threaten the vision of those afflicted.